Ocugen, Inc. (OCGN) Q1 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning and welcome to Oxygen's first quarter 2025 financial results and business update. Please note that this call is being recorded at this time. All participant lines are in listen-only mode. Following the speaker's commentary, there will be a question and answer session. I will now turn the call over to Tiffany Hamilton, Oxygen's Head of Corporate Communications. You may begin. Thank you, Operator, and good morning, everyone. Joining me on today's call and webcast is Dr. Shankar Musunari, Occitans chairman, CEO, and co-founder, who will provide a business update and an overview of our clinical and operational progress. Ramesh Ramachandran, our chief accounting officer, is also on the call to provide a financial update for the quarter ended March 31st, 2025. Dr. Huma Kumar, our chief medical officer, will be available to answer questions following the presentation. This morning, we issued a press release detailing associated business and operational highlights for the first quarter of 2025. We encourage listeners to review the press release, which is available on our website at Ockingen.com. This call is being recorded, and a replay with the accompanying slide presentation will be available on the investor section of our website for approximately 45 days. This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. which are subject to risks and uncertainties. We may, in some cases, use terms such as predicts, believe, potential, proposed, continue, estimates, anticipates, expects, plans, intends, may, could, might, will, should, or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. Such statements include but are not limited to st...